MATERNUS-Kliniken-AG
XETRA:MAK

Watchlist Manager
MATERNUS-Kliniken-AG Logo
MATERNUS-Kliniken-AG
XETRA:MAK
Watchlist
Price: 1.36 EUR -3.55% Market Closed
Market Cap: 28.5m EUR
Have any thoughts about
MATERNUS-Kliniken-AG?
Write Note

Intrinsic Value

The intrinsic value of one MAK stock under the Base Case scenario is 11.21 EUR. Compared to the current market price of 1.36 EUR, MATERNUS-Kliniken-AG is Undervalued by 88%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MAK Intrinsic Value
11.21 EUR
Undervaluation 88%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
MATERNUS-Kliniken-AG

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MAK
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MAK cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about MAK?
Bearish
Neutral
Bullish

Fundamental Analysis

1.36 EUR
-3.55%
-3.55%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

MATERNUS-Kliniken-AG
DE
Health Care
Market Cap
28.5m EUR
IPO
Apr 2, 1997
Employees
1 643
Germany
Market Cap
28.5m EUR
Industry
Health Care
IPO
Apr 2, 1997
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about MATERNUS-Kliniken-AG

Provide an overview of the primary business activities
of MATERNUS-Kliniken-AG.

What unique competitive advantages
does MATERNUS-Kliniken-AG hold over its rivals?

What risks and challenges
does MATERNUS-Kliniken-AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MATERNUS-Kliniken-AG.

Provide P/S
for MATERNUS-Kliniken-AG.

Provide P/E
for MATERNUS-Kliniken-AG.

Provide P/OCF
for MATERNUS-Kliniken-AG.

Provide P/FCFE
for MATERNUS-Kliniken-AG.

Provide P/B
for MATERNUS-Kliniken-AG.

Provide EV/S
for MATERNUS-Kliniken-AG.

Provide EV/GP
for MATERNUS-Kliniken-AG.

Provide EV/EBITDA
for MATERNUS-Kliniken-AG.

Provide EV/EBIT
for MATERNUS-Kliniken-AG.

Provide EV/OCF
for MATERNUS-Kliniken-AG.

Provide EV/FCFF
for MATERNUS-Kliniken-AG.

Provide EV/IC
for MATERNUS-Kliniken-AG.

What are the Revenue projections
for MATERNUS-Kliniken-AG?

How accurate were the past Revenue estimates
for MATERNUS-Kliniken-AG?

What are the Net Income projections
for MATERNUS-Kliniken-AG?

How accurate were the past Net Income estimates
for MATERNUS-Kliniken-AG?

What are the EPS projections
for MATERNUS-Kliniken-AG?

How accurate were the past EPS estimates
for MATERNUS-Kliniken-AG?

What are the EBIT projections
for MATERNUS-Kliniken-AG?

How accurate were the past EBIT estimates
for MATERNUS-Kliniken-AG?

Compare the revenue forecasts
for MATERNUS-Kliniken-AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MATERNUS-Kliniken-AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MATERNUS-Kliniken-AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of MATERNUS-Kliniken-AG compared to its peers.

Compare the P/E ratios
of MATERNUS-Kliniken-AG against its peers.

Discuss the investment returns and shareholder value creation
comparing MATERNUS-Kliniken-AG with its peers.

Analyze the financial leverage
of MATERNUS-Kliniken-AG compared to its main competitors.

Show all profitability ratios
for MATERNUS-Kliniken-AG.

Provide ROE
for MATERNUS-Kliniken-AG.

Provide ROA
for MATERNUS-Kliniken-AG.

Provide ROIC
for MATERNUS-Kliniken-AG.

Provide ROCE
for MATERNUS-Kliniken-AG.

Provide Gross Margin
for MATERNUS-Kliniken-AG.

Provide Operating Margin
for MATERNUS-Kliniken-AG.

Provide Net Margin
for MATERNUS-Kliniken-AG.

Provide FCF Margin
for MATERNUS-Kliniken-AG.

Show all solvency ratios
for MATERNUS-Kliniken-AG.

Provide D/E Ratio
for MATERNUS-Kliniken-AG.

Provide D/A Ratio
for MATERNUS-Kliniken-AG.

Provide Interest Coverage Ratio
for MATERNUS-Kliniken-AG.

Provide Altman Z-Score Ratio
for MATERNUS-Kliniken-AG.

Provide Quick Ratio
for MATERNUS-Kliniken-AG.

Provide Current Ratio
for MATERNUS-Kliniken-AG.

Provide Cash Ratio
for MATERNUS-Kliniken-AG.

What is the historical Revenue growth
over the last 5 years for MATERNUS-Kliniken-AG?

What is the historical Net Income growth
over the last 5 years for MATERNUS-Kliniken-AG?

What is the current Free Cash Flow
of MATERNUS-Kliniken-AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for MATERNUS-Kliniken-AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
MATERNUS-Kliniken-AG

Current Assets 22.3m
Cash & Short-Term Investments 9.6m
Receivables 11.7m
Other Current Assets 995k
Non-Current Assets 128.3m
Long-Term Investments 979k
PP&E 114.1m
Intangibles 13.2m
Other Non-Current Assets -1k
Current Liabilities 76.4m
Accounts Payable 4.2m
Other Current Liabilities 72.1m
Non-Current Liabilities 129.8m
Long-Term Debt 127.1m
Other Non-Current Liabilities 2.7m
Efficiency

Earnings Waterfall
MATERNUS-Kliniken-AG

Revenue
159.4m EUR
Cost of Revenue
-21.7m EUR
Gross Profit
137.8m EUR
Operating Expenses
-140.9m EUR
Operating Income
-3.1m EUR
Other Expenses
-13m EUR
Net Income
-16.1m EUR

Free Cash Flow Analysis
MATERNUS-Kliniken-AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

MAK Profitability Score
Profitability Due Diligence

MATERNUS-Kliniken-AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional ROE
Positive Free Cash Flow
50/100
Profitability
Score

MATERNUS-Kliniken-AG's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

MAK Solvency Score
Solvency Due Diligence

MATERNUS-Kliniken-AG's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
22/100
Solvency
Score

MATERNUS-Kliniken-AG's solvency score is 22/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MAK Price Targets Summary
MATERNUS-Kliniken-AG

There are no price targets for MAK.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for MAK?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MAK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one MAK stock?

The intrinsic value of one MAK stock under the Base Case scenario is 11.21 EUR.

Is MAK stock undervalued or overvalued?

Compared to the current market price of 1.36 EUR, MATERNUS-Kliniken-AG is Undervalued by 88%.

Back to Top